Average Co-Inventor Count = 4.34
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (35 from 2,405 patents)
2. Schering Corporation (6 from 1,829 patents)
3. Intervet Inc. (3 from 247 patents)
4. Intervet International B.v. (2 from 104 patents)
5. Other (1 from 832,961 patents)
45 patents:
1. 11207312 - Metallo-beta-lactamase inhibitors and methods of use thereof
2. 10954240 - Compounds inhibiting leucine-rich repeat kinase enzyme activity
3. 10544130 - Metallo-beta-lactamase inhibitors
4. 10329291 - C5-C6-carbocyclic fused iminothiadiazine dioxides as BACE inhibitors, compositions, and their use
5. 10238743 - C5-C6-fused tricyclic iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use
6. 10227331 - Metallo-β-lactamase inhibitors
7. 10221163 - Metallo-beta-lactamase inhibitors
8. 10047098 - C5-C6-oxacyclic fused iminopyrimidinone compounds as bace inhibitors, compositions, and their use
9. 9957269 - S-imino-S-oxo iminothiazine compounds as bace inhibitors, compositions, and their use
10. 9802928 - C-6 spirocarbocyclic iminothiadiazine dioxides as BACE inhibitors, compositions, and their use
11. 9745324 - Iminothiadiazepane dioxide compounds as BACE inhibitors, compositions, and their use
12. 9725468 - C5-spiro iminothiazine dioxides as BACE inhibitors, compositions, and their use
13. 9718818 - Compounds inhibiting leucine-rich repeat kinase enzyme activity
14. 9688654 - Compounds inhibiting leucine-rich repeat kinase enzyme activity
15. 9687494 - Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use